Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9264830abb1546ae267a47cad928c5bd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 |
filingDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2539f55297d8d1a6d29bbd2e58bf865 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_770a17e113e09c537e7820872ae348c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d248b985aa28c5cb0552b755e3e2e529 |
publicationDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006153934-A1 |
titleOfInvention |
Combination therapies of cicletanine and magnesium |
abstract |
Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and magnesium for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201900006624-A1 |
priorityDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |